Protara Therapeutics Cash from Financing (TTM) Analysis

Protara Therapeutics Inc (TARA)

2.91 0.00 (0.00%) USD | NASDAQ | May 06, 16:00

2.91 0.00 (0.00%) After-Hours: 18:31

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-0.091M
September 30, 2023	-0.091M
June 30, 2023	-0.082M
March 31, 2023	-0.082M
December 31, 2022	-0.09M
September 30, 2022	-0.09M
June 30, 2022	-0.072M

Date	Value
March 31, 2022	-0.072M
December 31, 2021	-0.228M
September 30, 2021	10.49M
June 30, 2021	150.32M
March 31, 2021	149.94M
December 31, 2020	189.40M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.228M

Minimum

Dec 2021

189.40M

Maximum

Dec 2020

38.40M

Average

-0.082M

Median

Mar 2023

Cash from Financing (TTM) Benchmarks